The obesity drug market faces intense competition in 2026 as Novo Nordisk and Eli Lilly launch oral pills, generics enter, and prices drop globally. India and China prepare for major opportunities.
Allahabad High Court rejects petitions from Marion Biotech officials challenging summons for using toxic ethylene glycol in cough syrup linked to child deaths in Uzbekistan.
Nine people in Singapore developed serious skin conditions after taking unregistered Modafinil and Armodafinil tablets manufactured in India's Dehradun without prescriptions.
The Supreme Court has sought responses on a PIL to declare AYUSH doctors as Registered Medical Practitioners and update a 1954 drug advertisement law. Read the full details and implications.
Tarn Taran police intensify the war on drugs with Phase 2. SSP Ranjit Singh leads a major crackdown, seizing assets and arresting peddlers. Read the full strategy.
Shark Tank India judge Namita Thapar reveals her founder journey with Arth, discarding products worth Rs 30 lakh and learning from her own investees. Discover her transition from Emcure's executive to startup hustler.
In a NYT interview, Donald Trump revealed he hasn't used GLP-1 drugs like Ozempic, sparking debate on obesity, healthcare costs, and his administration's drug price policies. Read the full story.
Punjab health department's special drive in Ludhiana finds three firms illegally stocking MTP kits. Show-cause notices issued, strict legal action promised. Read more.
Get MarketSmith India's expert stock recommendations for 8 January. Discover why Persistent Systems and Torrent Pharmaceuticals are top buys amid market consolidation.
India's amended pharma guidelines allow firms to settle minor violations via fines, avoiding court. The move aims to ease regulatory burden under the Drugs and Cosmetics Act. Read the full details.
India introduces a formal mechanism for drug and medical device firms to settle minor regulatory violations by paying fines, aiming to reduce court burdens and focus on serious health risks. Learn how the new compounding rules work.
The Pune Public Policy Festival is back at Gokhale Institute on Jan 9-10, 2026, exploring 'Decoding Technology and Society'. Discover insights on tech's role in India's global future. Read more!
Jammu administration cracks down on narcotics via courier. New order mandates valid permits for transport, violators face strict action. Read the full story.
A factory security guard in Udham Singh Nagar was murdered by his own nephew after a night of alcohol and drugs. The accused has been arrested. Read the full story.
Kanpur DM orders strict action against counterfeit drugs & adulterated food. 192 of 5250 food samples failed tests in FY 2025-26. Hygiene ratings given to 409 establishments.
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
The Indian government has prohibited the manufacture and sale of high-dose Nimesulide painkillers, citing health risks. Safer alternatives are available. Read the full details and implications.
A senior finance executive resigns from Akums Drugs citing Delhi's toxic air, sparking debate on health costs of pollution. Read his full story and the company's response.
A Bengaluru software engineer was arrested for allegedly manufacturing synthetic drugs like MDMA in a makeshift home laboratory. Police seized drugs worth lakhs and equipment. Read the shocking details.
Rajkumar Bafna, Finance President of Akums Drugs, resigns citing severe Delhi pollution as the primary reason. Read the full story on this corporate exit driven by environmental concerns.
A senior pharmaceutical executive resigns, citing Delhi's severe air pollution as the primary reason. This drastic move highlights the city's escalating public health emergency. Read more about the human cost of India's air quality crisis.
Drugs Control Administration officials raided an unlicensed clinic in Karimnagar, seizing illegal steroids and antibiotics. The crackdown highlights the public health risks of unauthorized drug sales. Read more.
Rajkumar Bafna, President of Finance at Akums Drugs, resigns citing Delhi's toxic air. His case highlights a growing trend of professionals leaving the capital for health reasons. Read the full story.
FDA registers case against Digras chemist for selling counterfeit drugs procured via an online shopping site. Lab tests in May confirmed the fraud. Read the full investigation details.
Cosmo Pharmaceuticals' clascoterone 5% solution shows significant hair regrowth in men with androgenetic alopecia. Could be the first new treatment mechanism in over three decades. Read more.
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
Kunal Yaduvanshi, 5, survived toxic Coldrif syrup but lost his eyesight. His father Tikku recounts the 116-day battle, financial ruin, and demands govt support for future treatment. Read the full story.
Panjab University VC Renu Vig launched a book on nanotech in food and drugs. It explores regulatory, ethical aspects and applications in cancer treatment. Read more.
Mirae Asset's Somil Mehta recommends NMDC, Glenmark Pharma, and BHEL for December 23, 2025. Get detailed technical analysis, buy ranges, targets, and stop-loss levels.